Global Geriatric Medicine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Geriatric Medicine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Geriatric Medicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Analgesics
1.2.3 Antihypertensives
1.2.4 Statins
1.2.5 Antidiabetics
1.2.6 Proton Pump Inhibitor
1.2.7 Anticoagulant
1.2.8 Antipsychotic
1.2.9 Antidepressant
1.3 Market by Application
1.3.1 Global Geriatric Medicine Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Cardiovascular
1.3.3 Arthritis
1.3.4 Neurological
1.3.5 Cancer
1.3.6 Osteoporosis
1.3.7 Respiratory
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Geriatric Medicine Market Size (2017-2028)
2.2 Geriatric Medicine Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Geriatric Medicine Market Size by Region (2017-2022)
2.4 Global Geriatric Medicine Market Size Forecast by Region (2023-2028)
2.5 Global Top Geriatric Medicine Countries Ranking by Market Size
3 Geriatric Medicine Competitive by Company
3.1 Global Geriatric Medicine Revenue by Players
3.1.1 Global Geriatric Medicine Revenue by Players (2017-2022)
3.1.2 Global Geriatric Medicine Market Share by Players (2017-2022)
3.2 Global Geriatric Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Geriatric Medicine Revenue
3.4 Global Geriatric Medicine Market Concentration Ratio
3.4.1 Global Geriatric Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Geriatric Medicine Revenue in 2021
3.5 Global Geriatric Medicine Key Players Head office and Area Served
3.6 Key Players Geriatric Medicine Product Solution and Service
3.7 Date of Enter into Geriatric Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Geriatric Medicine Breakdown Data by Type
4.1 Global Geriatric Medicine Historic Revenue by Type (2017-2022)
4.2 Global Geriatric Medicine Forecasted Revenue by Type (2023-2028)
5 Global Geriatric Medicine Breakdown Data by Application
5.1 Global Geriatric Medicine Historic Market Size by Application (2017-2022)
5.2 Global Geriatric Medicine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Geriatric Medicine Revenue by Company (2020-2022)
6.2 North America Geriatric Medicine Revenue by Type (2017-2028)
6.3 North America Geriatric Medicine Revenue by Application (2017-2028)
6.4 North America Geriatric Medicine Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Geriatric Medicine Revenue by Company (2020-2022)
7.2 Europe Geriatric Medicine Revenue by Type (2017-2028)
7.3 Europe Geriatric Medicine Revenue by Application (2017-2028)
7.4 Europe Geriatric Medicine Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Geriatric Medicine Revenue by Company (2020-2022)
8.2 Asia Pacific Geriatric Medicine Revenue by Type (2017-2028)
8.3 Asia Pacific Geriatric Medicine Revenue by Application (2017-2028)
8.4 Asia Pacific Geriatric Medicine Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Geriatric Medicine Revenue by Company (2020-2022)
9.2 Latin America Geriatric Medicine Revenue by Type (2017-2028)
9.3 Latin America Geriatric Medicine Revenue by Application (2017-2028)
9.4 Latin America Geriatric Medicine Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Geriatric Medicine Revenue by Company (2020-2022)
10.2 Middle East and Africa Geriatric Medicine Revenue by Type (2017-2028)
10.3 Middle East and Africa Geriatric Medicine Revenue by Application (2017-2028)
10.4 Middle East and Africa Geriatric Medicine Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Geriatric Medicine Products and Services
11.1.4 GSK Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022)
11.1.5 GSK Geriatric Medicine SWOT Analysis
11.1.6 GSK Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Geriatric Medicine Products and Services
11.2.4 Boehringer Ingelheim Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022)
11.2.5 Boehringer Ingelheim Geriatric Medicine SWOT Analysis
11.2.6 Boehringer Ingelheim Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Geriatric Medicine Products and Services
11.3.4 Novartis Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022)
11.3.5 Novartis Geriatric Medicine SWOT Analysis
11.3.6 Novartis Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Geriatric Medicine Products and Services
11.4.4 Bristol-Myers Squibb Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022)
11.4.5 Bristol-Myers Squibb Geriatric Medicine SWOT Analysis
11.4.6 Bristol-Myers Squibb Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Geriatric Medicine Products and Services
11.5.4 Pfizer Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022)
11.5.5 Pfizer Geriatric Medicine SWOT Analysis
11.5.6 Pfizer Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Geriatric Medicine Products and Services
11.6.4 Eli Lilly Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022)
11.6.5 Eli Lilly Geriatric Medicine SWOT Analysis
11.6.6 Eli Lilly Recent Developments
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Geriatric Medicine Products and Services
11.7.4 Abbott Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022)
11.7.5 Abbott Geriatric Medicine SWOT Analysis
11.7.6 Abbott Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Geriatric Medicine Products and Services
11.8.4 AstraZeneca Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022)
11.8.5 AstraZeneca Geriatric Medicine SWOT Analysis
11.8.6 AstraZeneca Recent Developments
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Geriatric Medicine Products and Services
11.9.4 Merck Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022)
11.9.5 Merck Geriatric Medicine SWOT Analysis
11.9.6 Merck Recent Developments
11.10 Sanofi S.A.
11.10.1 Sanofi S.A. Company Details
11.10.2 Sanofi S.A. Business Overview
11.10.3 Sanofi S.A. Geriatric Medicine Products and Services
11.10.4 Sanofi S.A. Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022)
11.10.5 Sanofi S.A. Geriatric Medicine SWOT Analysis
11.10.6 Sanofi S.A. Recent Developments
12 Geriatric Medicine Market Dynamics
12.1 Geriatric Medicine Market Trends
12.2 Geriatric Medicine Market Drivers
12.3 Geriatric Medicine Market Challenges
12.4 Geriatric Medicine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Geriatric Medicine Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Analgesics
Table 3. Key Players of Antihypertensives
Table 4. Key Players of Statins
Table 5. Key Players of Antidiabetics
Table 6. Key Players of Proton Pump Inhibitor
Table 7. Key Players of Anticoagulant
Table 8. Key Players of Antipsychotic
Table 9. Key Players of Antidepressant
Table 10. Global Geriatric Medicine Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 11. Global Geriatric Medicine Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 12. Global Geriatric Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Geriatric Medicine Revenue Market Share by Region (2017-2022)
Table 14. Global Geriatric Medicine Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Geriatric Medicine Market Share by Players (2017-2022)
Table 16. Global Top Geriatric Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geriatric Medicine as of 2021)
Table 17. Ranking of Global Top Geriatric Medicine Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Geriatric Medicine Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Geriatric Medicine Product Solution and Service
Table 21. Date of Key Manufacturers Enter into Geriatric Medicine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Geriatric Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Geriatric Medicine Revenue Market Share by Type (2017-2022)
Table 25. Global Geriatric Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Geriatric Medicine Revenue Market Share by Type (2023-2028)
Table 27. Global Geriatric Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Geriatric Medicine Revenue Market Share by Application (2017-2022)
Table 29. Global Geriatric Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Geriatric Medicine Revenue Market Share by Application (2023-2028)
Table 31. North America Geriatric Medicine Revenue by Company (2020-2022) & (US$ Million)
Table 32. North America Geriatric Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 33. North America Geriatric Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 34. North America Geriatric Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 35. North America Geriatric Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 36. North America Geriatric Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 37. North America Geriatric Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 38. Europe Geriatric Medicine Revenue by Company (2020-2022) & (US$ Million)
Table 39. Europe Geriatric Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 40. Europe Geriatric Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 41. Europe Geriatric Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 42. Europe Geriatric Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 43. Europe Geriatric Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 44. Europe Geriatric Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Geriatric Medicine Revenue by Company (2020-2022) & (US$ Million)
Table 46. Asia Pacific Geriatric Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Geriatric Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Geriatric Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Geriatric Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Geriatric Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Geriatric Medicine Revenue by Region (2023-2028) & (US$ Million)
Table 52. Latin America Geriatric Medicine Revenue by Company (2020-2022) & (US$ Million)
Table 53. Latin America Geriatric Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 54. Latin America Geriatric Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 55. Latin America Geriatric Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 56. Latin America Geriatric Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 57. Latin America Geriatric Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 58. Latin America Geriatric Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Geriatric Medicine Revenue by Company (2020-2022) & (US$ Million)
Table 60. Middle East and Africa Geriatric Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Geriatric Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Geriatric Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Geriatric Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Geriatric Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Geriatric Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 66. GSK Company Details
Table 67. GSK Business Overview
Table 68. GSK Geriatric Medicine Product and Services
Table 69. GSK Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022) & (US$ Million)
Table 70. GSK Geriatric Medicine SWOT Analysis
Table 71. GSK Recent Developments
Table 72. Boehringer Ingelheim Company Details
Table 73. Boehringer Ingelheim Business Overview
Table 74. Boehringer Ingelheim Geriatric Medicine Product and Services
Table 75. Boehringer Ingelheim Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022) & (US$ Million)
Table 76. Boehringer Ingelheim Geriatric Medicine SWOT Analysis
Table 77. Boehringer Ingelheim Recent Developments
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Geriatric Medicine Product and Services
Table 81. Novartis Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022) & (US$ Million)
Table 82. Novartis Geriatric Medicine SWOT Analysis
Table 83. Novartis Recent Developments
Table 84. Bristol-Myers Squibb Company Details
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb Geriatric Medicine Product and Services
Table 87. Bristol-Myers Squibb Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022) & (US$ Million)
Table 88. Bristol-Myers Squibb Geriatric Medicine SWOT Analysis
Table 89. Bristol-Myers Squibb Recent Developments
Table 90. Pfizer Company Details
Table 91. Pfizer Business Overview
Table 92. Pfizer Geriatric Medicine Product and Services
Table 93. Pfizer Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022) & (US$ Million)
Table 94. Pfizer Geriatric Medicine SWOT Analysis
Table 95. Pfizer Recent Developments
Table 96. Eli Lilly Company Details
Table 97. Eli Lilly Business Overview
Table 98. Eli Lilly Geriatric Medicine Product and Services
Table 99. Eli Lilly Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022) & (US$ Million)
Table 100. Eli Lilly Geriatric Medicine SWOT Analysis
Table 101. Eli Lilly Recent Developments
Table 102. Abbott Company Details
Table 103. Abbott Business Overview
Table 104. Abbott Geriatric Medicine Product and Services
Table 105. Abbott Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022) & (US$ Million)
Table 106. Abbott Geriatric Medicine SWOT Analysis
Table 107. Abbott Recent Developments
Table 108. AstraZeneca Company Details
Table 109. AstraZeneca Business Overview
Table 110. AstraZeneca Geriatric Medicine Product and Services
Table 111. AstraZeneca Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022) & (US$ Million)
Table 112. AstraZeneca Geriatric Medicine SWOT Analysis
Table 113. AstraZeneca Recent Developments
Table 114. Merck Company Details
Table 115. Merck Business Overview
Table 116. Merck Geriatric Medicine Product and Services
Table 117. Merck Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022) & (US$ Million)
Table 118. Merck Geriatric Medicine SWOT Analysis
Table 119. Merck Recent Developments
Table 120. Sanofi S.A. Company Details
Table 121. Sanofi S.A. Business Overview
Table 122. Sanofi S.A. Geriatric Medicine Product and Services
Table 123. Sanofi S.A. Geriatric Medicine Revenue in Geriatric Medicine Business (2017-2022) & (US$ Million)
Table 124. Sanofi S.A. Geriatric Medicine SWOT Analysis
Table 125. Sanofi S.A. Recent Developments
Table 126. Geriatric Medicine Market Trends
Table 127. Geriatric Medicine Market Drivers
Table 128. Geriatric Medicine Market Challenges
Table 129. Geriatric Medicine Market Restraints
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Geriatric Medicine Sales Market Share by Type: 2021 VS 2028
Figure 2. Analgesics Features
Figure 3. Antihypertensives Features
Figure 4. Statins Features
Figure 5. Antidiabetics Features
Figure 6. Proton Pump Inhibitor Features
Figure 7. Anticoagulant Features
Figure 8. Antipsychotic Features
Figure 9. Antidepressant Features
Figure 10. Global Geriatric Medicine Sales Market Share by Application: 2021 VS 2028
Figure 11. Cardiovascular Case Studies
Figure 12. Arthritis Case Studies
Figure 13. Neurological Case Studies
Figure 14. Cancer Case Studies
Figure 15. Osteoporosis Case Studies
Figure 16. Respiratory Case Studies
Figure 17. Geriatric Medicine Report Years Considered
Figure 18. Global Geriatric Medicine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Geriatric Medicine Market Size 2017-2028 (US$ Million)
Figure 20. Global Geriatric Medicine Market Size Market Share by Region: 2021 VS 2028
Figure 21. Global Geriatric Medicine Revenue Market Share by Region in 2017 VS 2022
Figure 22. Global Top 10 Geriatric Medicine Countries Ranking by Market Size (US$ Million) in 2021
Figure 23. Global Geriatric Medicine Market Share by Players in 2021
Figure 24. Global Top Geriatric Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geriatric Medicine as of 2021)
Figure 25. The Top 10 and 5 Players Market Share by Geriatric Medicine Revenue in 2021
Figure 26. North America Geriatric Medicine Revenue Market Share by Company in 2021
Figure 27. North America Geriatric Medicine Revenue Market Share by Type (2017-2028)
Figure 28. North America Geriatric Medicine Revenue Market Share by Application (2017-2028)
Figure 29. North America Geriatric Medicine Revenue Share by Country (2017-2028)
Figure 30. U.S. Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 31. Canada Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 32. Europe Geriatric Medicine Revenue Market Share by Company in 2021
Figure 33. Europe Geriatric Medicine Revenue Market Share by Type (2017-2028)
Figure 34. Europe Geriatric Medicine Revenue Market Share by Application (2017-2028)
Figure 35. Europe Geriatric Medicine Revenue Share by Country (2017-2028)
Figure 36. Germany Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 37. France Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 38. U.K. Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 39. Italy Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 40. Russia Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 41. Asia Pacific Geriatric Medicine Revenue Market Share by Company in 2021
Figure 42. Asia Pacific Geriatric Medicine Revenue Market Share by Type (2017-2028)
Figure 43. Asia Pacific Geriatric Medicine Revenue Market Share by Application (2017-2028)
Figure 44. Asia Pacific Geriatric Medicine Revenue Share by Region (2017-2028)
Figure 45. China Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 46. Japan Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 47. South Korea Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 48. India Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 49. Australia Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 50. Taiwan Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 51. Indonesia Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 52. Thailand Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 53. Malaysia Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 54. Philippines Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 55. Vietnam Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 56. Latin America Geriatric Medicine Revenue Market Share by Company in 2021
Figure 57. Latin America Geriatric Medicine Revenue Market Share by Type (2017-2028)
Figure 58. Latin America Geriatric Medicine Revenue Market Share by Application (2017-2028)
Figure 59. Latin America Geriatric Medicine Revenue Share by Country (2017-2028)
Figure 60. Mexico Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 61. Brazil Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 62. Argentina Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 63. Middle East and Africa Geriatric Medicine Revenue Market Share by Company in 2021
Figure 64. Middle East and Africa Geriatric Medicine Revenue Market Share by Type (2017-2028)
Figure 65. Middle East and Africa Geriatric Medicine Revenue Market Share by Application (2017-2028)
Figure 66. Middle East and Africa Geriatric Medicine Revenue Share by Country (2017-2028)
Figure 67. Turkey Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 68. Saudi Arabia Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 69. UAE Geriatric Medicine Revenue (2017-2028) & (US$ Million)
Figure 70. GSK Revenue Growth Rate in Geriatric Medicine Business (2017-2022)
Figure 71. Boehringer Ingelheim Revenue Growth Rate in Geriatric Medicine Business (2017-2022)
Figure 72. Novartis Revenue Growth Rate in Geriatric Medicine Business (2017-2022)
Figure 73. Bristol-Myers Squibb Revenue Growth Rate in Geriatric Medicine Business (2017-2022)
Figure 74. Pfizer Revenue Growth Rate in Geriatric Medicine Business (2017-2022)
Figure 75. Eli Lilly Revenue Growth Rate in Geriatric Medicine Business (2017-2022)
Figure 76. Abbott Revenue Growth Rate in Geriatric Medicine Business (2017-2022)
Figure 77. AstraZeneca Revenue Growth Rate in Geriatric Medicine Business (2017-2022)
Figure 78. Merck Revenue Growth Rate in Geriatric Medicine Business (2017-2022)
Figure 79. Sanofi S.A. Revenue Growth Rate in Geriatric Medicine Business (2017-2022)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs